TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 187 filers reported holding TG THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,710,038 | -75.0% | 204,550 | -25.6% | 0.00% | -100.0% |
| Q2 2023 | $6,830,255 | +12.2% | 274,970 | -32.1% | 0.00% | 0.0% |
| Q1 2023 | $6,087,000 | +178666.5% | 404,748 | +40.6% | 0.00% | – |
| Q4 2022 | $3,405 | -99.8% | 287,816 | -0.3% | 0.00% | – |
| Q3 2022 | $1,710,000 | +38.2% | 288,758 | -0.8% | 0.00% | – |
| Q2 2022 | $1,237,000 | -51.6% | 290,989 | +8.4% | 0.00% | – |
| Q1 2022 | $2,554,000 | -48.3% | 268,454 | +3.2% | 0.00% | -100.0% |
| Q4 2021 | $4,942,000 | -7.5% | 260,111 | +62.1% | 0.00% | 0.0% |
| Q3 2021 | $5,341,000 | -15.3% | 160,476 | -1.3% | 0.00% | 0.0% |
| Q2 2021 | $6,309,000 | -25.3% | 162,640 | -7.2% | 0.00% | 0.0% |
| Q1 2021 | $8,451,000 | +1.3% | 175,323 | +9.3% | 0.00% | 0.0% |
| Q4 2020 | $8,344,000 | +80.6% | 160,394 | -9.2% | 0.00% | 0.0% |
| Q3 2020 | $4,621,000 | +29.2% | 176,619 | -3.8% | 0.00% | 0.0% |
| Q2 2020 | $3,578,000 | +77.8% | 183,643 | -10.2% | 0.00% | – |
| Q1 2020 | $2,012,000 | -28.4% | 204,572 | -19.2% | 0.00% | -100.0% |
| Q4 2019 | $2,809,000 | +83.2% | 253,096 | -7.3% | 0.00% | – |
| Q3 2019 | $1,533,000 | -25.6% | 273,088 | +5.7% | 0.00% | – |
| Q2 2019 | $2,061,000 | -5.1% | 258,296 | -4.3% | 0.00% | – |
| Q1 2019 | $2,171,000 | +84.1% | 269,998 | -6.2% | 0.00% | – |
| Q4 2018 | $1,179,000 | -30.9% | 287,718 | -5.5% | 0.00% | – |
| Q3 2018 | $1,705,000 | -54.4% | 304,497 | +7.0% | 0.00% | -100.0% |
| Q2 2018 | $3,742,000 | -12.2% | 284,540 | -5.2% | 0.00% | 0.0% |
| Q1 2018 | $4,264,000 | -7.1% | 300,237 | -46.3% | 0.00% | 0.0% |
| Q4 2017 | $4,589,000 | +8.7% | 559,553 | +56.5% | 0.00% | 0.0% |
| Q3 2017 | $4,220,000 | +15.4% | 357,625 | -1.8% | 0.00% | 0.0% |
| Q2 2017 | $3,658,000 | +24.2% | 364,025 | +44.0% | 0.00% | 0.0% |
| Q1 2017 | $2,946,000 | +1707.4% | 252,870 | +619.5% | 0.00% | – |
| Q4 2016 | $163,000 | +16200.0% | 35,146 | +22286.0% | 0.00% | – |
| Q2 2016 | $1,000 | 0.0% | 157 | 0.0% | 0.00% | – |
| Q1 2016 | $1,000 | -100.0% | 157 | -100.0% | 0.00% | -100.0% |
| Q4 2014 | $12,646,000 | -27.1% | 798,361 | -50.9% | 0.00% | -25.0% |
| Q3 2014 | $17,344,000 | -18.8% | 1,625,529 | -28.5% | 0.00% | -20.0% |
| Q2 2014 | $21,351,000 | +9.5% | 2,273,776 | -19.5% | 0.01% | 0.0% |
| Q1 2014 | $19,493,000 | +26602.7% | 2,825,036 | +24484.8% | 0.01% | – |
| Q2 2013 | $73,000 | – | 11,491 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,890,000 | $15,800,400 | 5.14% |
| Ghost Tree Capital, LLC | 1,000,000 | $8,360,000 | 2.75% |
| Soleus Capital Management, L.P. | 2,884,382 | $24,113,434 | 2.22% |
| M28 Capital Management LP | 216,600 | $1,810,776 | 2.08% |
| Paradigm Biocapital Advisors LP | 3,619,015 | $30,254,965 | 2.05% |
| 683 Capital Management, LLC | 1,350,000 | $11,286,000 | 0.88% |
| Parkwood LLC | 165,414 | $6,081 | 0.66% |
| Spotlight Asset Group, Inc. | 79,000 | $660,440 | 0.60% |
| Pier Capital, LLC | 392,709 | $3,283,047 | 0.53% |
| Quantum Private Wealth, LLC | 91,081 | $761,438 | 0.36% |